TransMedics Group (TMDX) Revenue & Revenue Breakdown
TransMedics Group Revenue Highlights
Latest Revenue (Y)
$241.62M
Latest Revenue (Q)
$-12.24M
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
TransMedics Group Revenue by Period
TransMedics Group Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $241.62M | 158.53% |
2022-12-31 | $93.46M | 208.83% |
2021-12-31 | $30.26M | 18.03% |
2020-12-31 | $25.64M | 8.62% |
2019-12-28 | $23.60M | 81.33% |
2018-12-31 | $13.02M | 69.38% |
2017-12-31 | $7.68M | 23.77% |
2016-12-31 | $6.21M | - |
TransMedics Group Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $-12.24M | -110.71% |
2024-06-30 | $114.31M | 18.02% |
2024-03-31 | $96.85M | 19.31% |
2023-12-31 | $81.17M | 22.19% |
2023-09-30 | $66.43M | 26.62% |
2023-06-30 | $52.47M | 26.26% |
2023-03-31 | $41.55M | 32.44% |
2022-12-31 | $31.38M | 22.16% |
2022-09-30 | $25.68M | 25.15% |
2022-06-30 | $20.52M | 29.23% |
2022-03-31 | $15.88M | 64.25% |
2021-12-31 | $9.67M | 80.04% |
2021-09-30 | $5.37M | -34.28% |
2021-06-30 | $8.17M | 15.85% |
2021-03-31 | $7.05M | -7.53% |
2020-12-31 | $7.63M | 7.56% |
2020-09-30 | $7.09M | 109.11% |
2020-06-30 | $3.39M | -54.97% |
2020-03-31 | $7.53M | 24.32% |
2019-12-28 | $6.06M | -15.93% |
2019-09-28 | $7.21M | 27.16% |
2019-06-29 | $5.67M | 21.17% |
2019-03-30 | $4.68M | 31.94% |
2018-12-31 | $3.54M | -12.26% |
2018-09-30 | $4.04M | 38.56% |
2018-06-30 | $2.92M | 15.72% |
2018-03-31 | $2.52M | 19.61% |
2017-12-30 | $2.11M | 12.80% |
2017-09-30 | $1.87M | -16.35% |
2017-07-01 | $2.23M | - |
TransMedics Group Revenue Breakdown
TransMedics Group Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Product | $176.05M | $79.23M | - | - | - |
Service Revenue | $65.55M | $14.22M | - | - | - |
Ocs Lung Product | - | - | $10.66M | $6.19M | $8.66M |
Ocs Liver Product | - | - | $1.91M | $5.25M | $3.50M |
Ocs Heart Product | - | - | $17.68M | $14.20M | $11.44M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product | $65.86M | $71.73M | $61.33M | $88.51M | $11.09M | $42.46M | $33.99M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Service | $42.90M | $42.57M | $35.52M | $14.68M | $10.00M | $7.56M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Ocs Liver Product | - | - | - | - | - | - | - | $12.54M | $9.62M | $7.87M | $1.47M | - | - | $442.00K | $2.12M | $1.00M | $736.00K | - | $1.35M | - |
Ocs Lung Product | - | - | - | - | - | - | - | $1.60M | $2.84M | $2.30M | $2.14M | $2.52M | $3.57M | $2.43M | $3.09M | $659.00K | $435.00K | $2.92M | $2.11M | - |
Ocs Heart Product | - | - | - | - | - | - | - | $11.54M | $8.06M | $5.71M | $6.05M | $2.85M | $4.60M | $4.18M | $2.42M | $5.43M | $2.22M | $3.14M | $3.74M | - |
OCS Liver Product | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.39M | - | - |
OCS Heart Product | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.13M | - | - |
OCS Lung Product | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.01M | - | - |
Latest
TransMedics Group Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|
Other Countries | $880.00K | $3.97M | - | - |
UNITED STATES | $7.97M | $21.86M | $19.24M | $16.25M |
Non Us And Uk | - | $8.40M | $6.40M | - |
GERMANY | - | - | - | $1.15M |
Latest
Quarterly Revenue by Country
Country | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Countries | $403.00K | $4.05M | $2.32M | $2.40M | $1.20M | $1.65M | $139.00K | - | - | - | - | - | - | - | - | - | - | - |
UNITED STATES | $2.82M | $37.50M | $29.05M | $23.29M | $18.14M | $13.56M | $7.23M | $5.76M | $5.76M | $5.67M | $5.92M | $2.44M | $5.21M | $4.66M | $4.34M | $4.30M | $2.95M | - |
Non Us And Uk | - | - | - | - | $2.38M | $2.32M | $4.36M | $1.90M | $1.31M | $824.00K | $4.10M | $491.00K | $596.00K | - | - | - | - | - |
U S | - | - | - | - | - | - | - | $3.11M | - | - | - | - | - | - | - | - | - | - |
Non US And UK | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.21M | - | - | - | - |
GERMANY | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $276.00K | $194.00K | $358.00K | - |
AUSTRALIA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $251.00K | $175.00K | - |
ITALY | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $287.00K | - |
Non-US | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.72M |
Latest
TransMedics Group Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
MASI | Masimo | $2.05B | $504.60M |
PODD | Insulet | $1.70B | $372.60M |
PEN | Penumbra | $1.06B | $301.04M |
INSP | Inspire Medical Systems | $624.80M | $203.19M |
NARI | Inari Medical | $493.63M | $153.39M |
INMD | InMode | $492.05M | $80.28M |
TMDX | TransMedics Group | $241.62M | $-12.24M |
LUNG | Pulmonx | $68.67M | $20.39M |
NPCE | NeuroPace | $65.42M | $21.06M |
TELA | TELA Bio | $58.45M | $18.96M |
CVRX | CVRx | $39.30M | $13.37M |
DCTH | Delcath Systems | $2.06M | $9.56M |
OFIX | Orthofix Medical | $100.00K | $198.62M |